health

tapeworm-in-fox-poop-that-will-slowly-destroy-your-organs-is-on-the-rise

Tapeworm in fox poop that will slowly destroy your organs is on the rise

No matter how bad things might seem, at least you haven’t accidentally eaten fox poop and developed an insidious tapeworm infection that masquerades as a cancerous liver tumor while it slowly destroys your organs and eventually kills you—or, you probably haven’t done that.

What’s more, according to a newly published study in Emerging Infectious Diseases, even if you have somehow feasted on fox feces and acquired this nightmare parasite, it’s looking less likely that doctors will need to hack out chunks of your organs to try to stop it.

That’s the good news from the new study. The bad news is that, while this infection is fairly rare, it appears to be increasing. And, if you do get it, you might have a shorter lifespan than the uninfected and may be sicker in general.

Meet the fox tapeworm

The new study is a retrospective one, in which a group of doctors in Switzerland examined medical records of 334 patients who developed the disease alveolar echinococcosis (AE) over a 50-year span (1973–2022). AE is an understudied, life-threatening infection caused by the fox tapeworm, Echinococcus multilocularis. The parasite is not common, but can be found throughout the Northern Hemisphere, particularly regions of China and Russia, and countries in continental Europe and North America.

In the parasite’s intended lifecycle, adult intestinal worms release eggs into the feces of their primary host—foxes, or sometimes coyotes, dogs, or other canids. The eggs then get ingested by an intermediate host, such as voles. There, eggs develop into a spherical embryo with six hooks that pierce through the intestinal wall to migrate to the animal’s organs, primarily the liver. Once nestled into an organ, the parasites develop into multi-chambered, thin-walled cysts—a proliferative life stage that lasts indefinitely. As more cysts develop, the mass looks and acts like cancer, forming necrotic cavities and sometimes metastasizing to other organs, such as the lungs and brain. The parasite remains in these cancerous-like masses, waiting for a fox to eat the cyst-riddled organs of its host. Back in a fox, the worms attach to the intestines and grow into adults.

Tapeworm in fox poop that will slowly destroy your organs is on the rise Read More »

drunk-man-walks-into-climate-change,-burns-the-bottoms-of-his-feet-off

Drunk man walks into climate change, burns the bottoms of his feet off

In the burn unit, doctors gave the man a pain reliever, cleaned the burns, treated them with a topical antibiotic, and gave them an antimicrobial foam dressing. At a follow-up appointment, the wounds appeared to be healing without complications.

While the man recovered from the injury, the author of the case study—Jeremy Hess, an expert in emergency medicine and global environmental health at the University of Washington—warned that the risk of such injuries will only grow as climate change continues.

“Extreme heat events increase the risk of contact burns from hot surfaces in the environment,” he wrote. “Young children, older adults, unhoused persons, and persons with substance use disorder are at elevated risk for these types of burns.”

Last year, The New York Times reported that burn centers in the southwest have already begun seeing larger numbers of burns from contact with sidewalks and asphalt during heat waves. In some cases, the burns can turn fatal if people lose consciousness on hot surfaces—for instance, from overdoses, heat stroke, intoxication, or other health conditions. “Your body just literally sits there and cooks,” Clifford Sheckter, surgeon and a burn prevention researcher at Stanford University, told the Times last year. “When somebody finally finds you, you’re already in multisystem organ failure.”

Drunk man walks into climate change, burns the bottoms of his feet off Read More »

controversial-doc-gets-measles-while-treating-unvaccinated-kids—keeps-working

Controversial doc gets measles while treating unvaccinated kids—keeps working

In the video with Edwards that has just come to light, CHD once again uses the situation to disparage MMR vaccines. Someone off camera asks Edwards if he had never had measles before, to which he replies that he had gotten an MMR vaccine as a kid, though he didn’t know if he had gotten one or the recommended two doses.

“That doesn’t work then, does it?” the off-camera person asks, referring to the MMR vaccine. “No, apparently not, ” Edwards replies. “Just wear[s] off.”

It appears Edwards had a breakthrough infection, which is rare, but it does occur. They’re more common in people who have only gotten one dose, which is possibly the case for Edwards.

A single dose of MMR is 93 percent effective against measles, and two doses are 97 percent effective. In either case, the protection is considered lifelong.

While up to 97 percent effectiveness is extremely protective, some people do not mount protective responses and are still vulnerable to an infection upon exposure. However, their illnesses will likely be milder than if they had not been vaccinated. In the video, Edwards described his illness as a “mild case.”

The data on the outbreak demonstrates the effectiveness of vaccination. As of April 18, Texas health officials have identified 597 measles cases, leading to 62 hospitalizations and two deaths in school-aged, unvaccinated children with no underlying medical conditions. Most of the cases have been in unvaccinated children. Of the 597 cases, 12 (2 percent) had received two MMR doses previously, and 10 (1.6 percent) had received one dose. The remaining 96 percent of cases are either unvaccinated or have no record of vaccination.

Toward the end of the video, Edwards tells CHD he’s “doing what any doctor should be doing.”

Controversial doc gets measles while treating unvaccinated kids—keeps working Read More »

neuroscientists-are-racing-to-turn-brain-waves-into-speech

Neuroscientists are racing to turn brain waves into speech

Many thousands of people a year could benefit from so-called voice prosthesis. Their cognitive functions remain more or less intact, but they have suffered speech loss due to stroke, the neurodegenerative disorder ALS, and other brain conditions. If successful, researchers hope the technique could be extended to help people who have difficulty vocalizing because of conditions such as cerebral palsy or autism.

The potential of voice neuroprosthesis is beginning to trigger interest among businesses. Precision Neuroscience claims to be capturing higher resolution brain signals than academic researchers, since the electrodes of its implants are more densely packed.

The company has worked with 31 patients and plans soon to collect data from more, providing a potential pathway to commercialization.

Precision received regulatory clearance on April 17 to leave its sensors implanted for up to 30 days at a time. That would enable its scientists to train their system with what could within a year be the “largest repository of high resolution neural data that exists on planet Earth,” said chief executive Michael Mager.

The next step would be to “miniaturize the components and put them in hermetically sealed packages that are biocompatible so they can be planted in the body forever,” Mager said.

Elon Musk’s Neuralink, the best-known brain-computer interface (BCI) company, has focused on enabling people with paralysis to control computers rather than giving them a synthetic voice.

An important obstacle to the development of brain-to-voice technology is the time patients take to learn how to use the system.

A key unanswered question is how much the response patterns in the motor cortex—the part of the brain that controls voluntary actions, including speech—vary between people. If they remained very similar, machine-learning models trained on previous individuals could be used for new patients, said Nick Ramsey, a BCI researcher at University Medical Centre Utrecht.

Neuroscientists are racing to turn brain waves into speech Read More »

“lab-leak”-marketing-page-replaces-federal-hub-for-covid-resources

“Lab leak” marketing page replaces federal hub for COVID resources

After obliterating the federal office on long COVID and clawing back billions in COVID funding from state health departments, the Trump administration has now entirely erased the online hub for federal COVID-19 resources. In its place now stands a site promoting the unproven idea that the pandemic virus SARS-CoV-2 was generated in and leaked from a lab in China, sparking the global health crisis.

Navigating to COVID.gov brings up a slick site with rich content that lays out arguments and allegations supporting a lab-based origin of the pandemic and subsequent cover-up by US health officials and Democrats.

Previously, the site provided unembellished quick references to COVID-19 resources, including links to information on vaccines, testing, treatments, and long COVID. It also provided a link to resources for addressing COVID-19 vaccine misconceptions and confronting misinformation. That all appears to be gone now, though some of the same information still remains on a separate COVID-19 page hosted by the Centers for Disease Control and Prevention.

While there remains no definitive answer on how the COVID-19 pandemic began, the scientific data available on the topic points to a spillover event from a live wild animal market in Wuhan, China. The scientific community largely sees this as the most likely scenario, given the data so far and knowledge of how previous outbreak viruses originated, including SARS-CoV-1. By contrast, the lab origin hypothesis largely relies on the proximity of a research lab to the first cases, conjecture, and distrust of the Chinese government, which has not been forthcoming with information on the early days of the health crisis. Overall, the question of SARS-CoV-2’s origin has become extremely politicized, as have most other aspects of the pandemic.

“Lab leak” marketing page replaces federal hub for COVID resources Read More »

autism-rate-rises-slightly;-rfk-jr.-claims-he’ll-“have-answers-by-september”

Autism rate rises slightly; RFK Jr. claims he’ll “have answers by September”

Among the sites, there were large differences. Prevalence ranged from 9.7 per 1,000 children who were 8 years old in Texas (Laredo) to 53.1 in California. These differences are likely due to “differences in availability of services for early detection and evaluation and diagnostic practices,” the CDC and network researchers wrote.

For instance, California—the site with the highest prevalence among 8-year-olds and also 4-year-olds—has a local initiative called the Get SET Early model. “As part of the initiative, hundreds of local pediatricians have been trained to screen and refer children for assessment as early as possible, which could result in higher identification of ASD, especially at early ages,” the authors write. “In addition, California has regional centers throughout the state that provide evaluations and service coordination for persons with disabilities and their families.”

On the other hand, the low ASD rates at the network’s two Texas sites could “suggest lack of access or barriers to accessing identification services,” the authors say. The two Texas sites included primarily Hispanic and lower-income communities.

The newly revealed higher rates in some of the network’s underserved communities could link ASD prevalence to social determinants of health, such as low income and housing and food insecurity, the authors say. Other factors, such as higher rates of preterm birth, which is linked to neurodevelopmental disabilities, as well as lead poisoning and traumatic brain injuries, may also contribute to disparities.

Anti-vaccine voices

The detailed data-heavy report stands in contrast to the position of health secretary Robert F. Kennedy Jr., a longtime anti-vaccine advocate who promotes the false and thoroughly debunked claim that autism is caused by vaccines. Last month, Kennedy hired the discredited anti-vaccine advocate David Geier to lead a federal study examining whether vaccines cause autism, despite numerous high-quality studies already finding no link between the two.

Geier, who has no medical or scientific background, has long worked with his father, Mark Geier, to promote the idea that vaccines cause autism. In 2011, Mark Geier was stripped of his medical license for allegedly mistreating children with autism, and David Geier was fined for practicing medicine without a license.

In a media statement Tuesday in response to the new report, Kennedy called autism an “epidemic” that is “running rampant.” He appeared to reference his planned study with Geier, saying: “We are assembling teams of world-class scientists to focus research on the origins of the epidemic, and we expect to begin to have answers by September.”

Autism rate rises slightly; RFK Jr. claims he’ll “have answers by September” Read More »

ct-scans-could-cause-5%-of-cancers,-study-finds;-experts-note-uncertainty

CT scans could cause 5% of cancers, study finds; experts note uncertainty

Uncertainty and balancing

“The estimates, while based on the best models available to the authors, are indirect, so there is considerable uncertainty about the estimates,” Stephen Duffy, emeritus professor of Cancer Screening at Queen Mary University of London, said in a statement. “Thus, I would say to patients that if you are recommended to have a CT scan, it would be wise to do so.”

Duffy also highlighted that in the context of a person’s overall risk of cancer, CT scans don’t move the needle much. There were a little over 100,000 cancers linked to 93 million scans. “This amounts to around a 0.1 percent increase in cancer risk over the patient’s lifetime per CT examination,” he said. The lifetime risk of cancer in the US population is around 40 percent. Thus, the additional risk from CT scans “is small.” Overall, when a CT scan is deemed necessary, the “likely benefit in diagnosis and subsequent treatment of disease outweighs the very small increase in cancer risk.”

Doreen Lau, a cancer biology expert at Brunel University of London, agreed: “The findings don’t mean that people should avoid CT scans when recommended by a doctor. In most cases, the benefit of detecting or ruling out serious illness far outweighs the very small risk of harm.”

Still, the rise in CT scans in recent years may suggest that doctors could cut back on their use. In an accompanying editorial, Ilana Richman of Yale University and Mitchell Katz of NYC Health and Hospitals discussed ways that doctors could make sure they’re balancing risks and benefits before using CT scans, including using diagnostic algorithms and offering alternative imaging options, such as ultrasounds and magnetic resonance imaging (MRIs).

“As with all complex problems, there will be no simple solution,” they write. But, “educating clinicians about avoiding low-value testing and, in circumstances where alternatives are readily available, involving patients in the decision to do a CT scan may help shift culture and practice.”

CT scans could cause 5% of cancers, study finds; experts note uncertainty Read More »

holy-water-brimming-with-cholera-compels-illness-cluster-in-europe

Holy water brimming with cholera compels illness cluster in Europe

“As the infectious dose of V. cholerae O1 has been estimated to be 105–108 [100,000 to 100 million] colony-forming units (CFU), this suggests the holy water was heavily contaminated and bacteria remained viable at ambient temperature during the flight and in Europe,” the German and UK researchers who authored the report wrote.

Global plague

Testing indicated that the cholera strain that the travelers brought home was a particularly nasty one. V. cholerae O1, which is linked to other recent outbreaks in Eastern and Middle Africa, is resistant to a wide variety of antibiotics, namely: fluroquinolones, trimethoprim, chloramphenicol, aminoglycosides, beta-lactams, macrolides, and sulphonamides. The strain also carried a separate genetic element (a plasmid) that provided resistance mechanisms against streptomycin and spectinomycin, cephalosporins, macrolides, and sulphonamides.

The main treatment for cholera, which causes profuse watery diarrhea and vomiting, is oral rehydration. Antibiotics are sometimes used to reduce severity. Fortunately, this strain was still susceptible to the antibiotic tetracycline, one of the drugs of choice for cholera. However, there are reports of other cholera strains in Africa that have also acquired tetracycline resistance.

In all, “The extension of a cholera outbreak in Africa causing a cluster of infections in Europe is unusual,” the authors write. They call for travelers to be aware of infectious threats when eating and drinking abroad—and to not ingest holy water. Clinicians should also be aware of the potential of cholera in travelers to Ethiopia.

To truly fight cholera outbreaks, though, there needs to be sustained investment in water, sanitation, and hygiene (WASH). Cases of cholera have surged globally after the pandemic, according to the World Health Organization.

“Low-income countries will continue to need overseas development aid support to control outbreaks and epidemics using effective WASH, surveillance, communications, diagnostics and countermeasure programmatic delivery,” the authors of the Eurosurveillance report write.

Holy water brimming with cholera compels illness cluster in Europe Read More »

experimental-drug-looks-to-be-gastric-bypass-surgery-in-pill-form

Experimental drug looks to be gastric bypass surgery in pill form

In rats, the drug produced a consistent 1 percent weekly weight loss over a six-week study period while preserving 100 percent of lean muscle mass.

In a first-in-human pilot study of nine participants, the drug was safe with no adverse effects. Tissue samples taken from the intestine were used to confirm that the coating formed and was also cleared from the body within 24 hours. The study wasn’t designed to assess weight loss, but blood testing showed that after the drug was given, glucose levels and the “hunger hormone” ghrelin were lower while the levels of leptin, an appetite-regulating hormone, were higher.

“When nutrients are redirected to later in the intestine, you’re activating pathways that lead towards satiety, energy expenditure, and overall healthy, sustainable weight loss,” Dhanda says.

Syntis Bio’s findings in animals also hint at the drug’s potential for weight loss without compromising muscle mass, one of the concerns with current GLP-1 drugs. While weight loss in general is associated with numerous health benefits, there’s growing evidence that the kind of drastic weight loss that GLP-1s induce can also lead to a loss of lean muscle mass.

Louis Aronne, an obesity medicine specialist and professor of metabolic research at Weill-Cornell Medical College, says that while GLP-1s are wildly popular, they may not be right for everyone. He predicts that in the not-so-distant future there will be many drugs for obesity, and treatment will be more personalized. “I think Syntis’ compound fits in perfectly as a treatment that could be used early on. It’s a kind of thing you could use as a first-line medication,” he says. Arrone serves as a clinical adviser to the company.

Vladimir Kushnir, professor of medicine and director of bariatric endoscopy at Washington University in St. Louis, who isn’t involved with Syntis, says the early pilot data is encouraging, but it’s hard to draw any conclusions from such a small study. He expects that the drug will make people feel fuller but could also have some of the same side effects as gastric bypass surgery. “My anticipation is that this is going to have some digestive side effects like bloating and abdominal cramping, as well as potentially some diarrhea and nausea once it gets into a bigger study,” he says.

It’s early days for this novel technique, but if it proves effective, it could one day be an alternative or add-on drug to GLP-1 medications.

This story originally appeared on wired.com.

Experimental drug looks to be gastric bypass surgery in pill form Read More »

revolt-brews-against-rfk-jr.-as-experts-pen-rally-cries-in-top-medical-journal

Revolt brews against RFK Jr. as experts pen rally cries in top medical journal

“Courage and clarity”

In a more acerbic article, Vanderbilt researchers Jeremy Jacobs and Garrett Booth blasted Kennedy’s appointment of infamous anti-vaccine advocate David Geier to lead a federal study on immunizations and neurodevelopmental outcomes. Geier and his father, Mark Geier, were named in 2010 by Nature magazine to be among the top science deniers. The duo is known for endlessly promoting the exhaustively debunked false claim that vaccines cause autism, which Kennedy also promotes. Mark Geier was stripped of his medical license over accusations he mistreated children with autism, and David Geier, who has no medical background, was fined for practicing medicine without a license.

Jacobs and Booth argued that hiring David Geier compromises the integrity of the scientific process, erodes public trust, and provides a platform for unreliable information. It’s a “dangerous concession to pseudoscience,” they wrote.

“Elevating figures known for spreading unreliable information threatens not only the integrity of individual research efforts but also the broader public confidence in science,” they wrote. “It sends a message that fringe views deserve equal standing with evidence-based consensus.”

The moves from Kennedy highlight escalating threats to science and medicine, the researchers wrote. Like Edwards, they called for researchers and health experts to stand up to defend evidence-based medicine.

“At this critical juncture, public institutions and academic leaders must demonstrate courage and clarity,” they wrote. “If science is to remain a trusted foundation for public health, its stewards must be selected not for their ability to generate controversy, but for their commitment to truth. That requires rejecting the normalization of unreliable information and reaffirming our collective responsibility to safeguard the integrity of public health.”

Revolt brews against RFK Jr. as experts pen rally cries in top medical journal Read More »

parents-give-kids-more-melatonin-than-ever,-with-unknown-long-term-effects

Parents give kids more melatonin than ever, with unknown long-term effects


More children are taking the hormone in the form of nightly gummies or drops.

Two years ago, at a Stop & Shop in Rhode Island, the Danish neuroscientist and physician Henriette Edemann-Callesen visited an aisle stocked with sleep aids containing melatonin. She looked around in amazement. Then she took out her phone and snapped a photo to send to colleagues back home.

“It was really pretty astonishing,” she recalled recently.

In Denmark, as in many countries, the hormone melatonin is a prescription drug for treating sleep problems, mostly in adults. Doctors are supposed to prescribe it to children only if they have certain developmental disorders that make it difficult to sleep—and only after the family has tried other methods to address the problem.

But at the Rhode Island Stop & Shop, melatonin was available over the counter, as a dietary supplement, meaning it receives slightly less regulatory scrutiny, in some respects, than a package of Skittles. Many of the products were marketed for children, in colorful bottles filled with liquid drops and chewable tablets and bright gummies that look and taste like candy.

A quiet but profound shift is underway in American parenting, as more and more caregivers turn to pharmacological solutions to help children sleep. What makes that shift unusual is that it’s largely taking place outside the traditional boundaries of health care. Instead, it’s driven by the country’s sprawling dietary supplements industry, which critics have long said has little regulatory oversight—and which may get a boost from Secretary of Health and Human Services Robert F. Kennedy Jr., who is widely seen as an ally to supplement makers.

Thirty years ago, few people were giving melatonin to children, outside of a handful of controlled experiments. Even as melatonin supplements grew in popularity among adults in the late 1990s in the United States and Canada, some of those products carried strict warnings not to give them to younger people. But with time, the age floor dropped, and by the mid-2000s, news reports and academic surveys suggest some early adopters were doing just that. (Try it for ages 11-and-up only, one CNN report warned at the time.) By 2013, according to a Wall Street Journal article, a handful of companies were marketing melatonin products specifically for kids.

And today? “It’s almost like a vitamin now,” said Judith Owens, a pediatric sleep specialist at Harvard Medical School. Usage is growing, including among children who are barely out of diapers. Academic surveys suggest that as many as 1 in 5 preteens in the US now take melatonin at least occasionally, and that some younger children consume it multiple times per week.

Store shelves stocked with sleep aids

Sleep aids, many of them melatonin, are displayed for sale in a Florida store in 2023. In the US, melatonin is available over the counter, but in many other countries the hormone is a prescription drug mostly used by adults.

Credit: Joe Raedle/Getty Images

Sleep aids, many of them melatonin, are displayed for sale in a Florida store in 2023. In the US, melatonin is available over the counter, but in many other countries the hormone is a prescription drug mostly used by adults. Credit: Joe Raedle/Getty Images

On social media, parenting influencers film themselves dancing with bottles of melatonin gummies or cut to shots of their snoozing kids. In the toxicology literature, a series of reports suggest a rise in melatonin misuse—and indicate that some caregivers are even giving doses to infants. And according to multiple studies, some brands may contain substantially higher doses of the hormone than product labels indicate.

The trend has unsettled many childhood sleep researchers. “It is a hormone that you are giving to young children. And there’s just very little research on the long-term effects of this,” said Lauren Hartstein, a childhood sleep researcher at the University of Arizona.

In a 2021 journal article, David Kennaway, a professor of physiology at the University of Adelaide in Australia, noted that melatonin can bind to receptors in the pancreas, the heart, fat tissue, and reproductive organs. (Kennaway once held a patent on a veterinary drug that uses melatonin to boost the fertility of ewes.) Distributing the hormone over the counter to American children, he has argued, is akin to a vast, uncontrolled medical experiment.

“It is a hormone that you are giving to young children. And there’s just very little research on the long-term effects of this.”

To others, that kind of language might seem alarmist—especially considering that melatonin appears to have mild side effects, and that sleep problems themselves can have consequences for both child and parental health. Many caregivers report melatonin is helpful for their children, and it’s been given for years to children with autism and ADHD, who often struggle to sleep. Beth Malow, a neurologist and sleep medicine expert at Vanderbilt University Medical Center who has consulted for a pharmaceutical company that manufactures melatonin products, raised concerns about a tendency to highlight “the evils of melatonin” without noting that “it’s actually very safe, and it can be very helpful.” Focusing just on the negatives, she added, “is to throw the baby out with the bathwater.”

All of this leaves parents navigating a lightly regulated marketplace while receiving conflicting medical advice. “We know that not getting enough sleep in early childhood has a lot of bad effects on health and attention and cognition and emotions, et cetera,” said Hartstein. Meanwhile, she added, “melatonin is safe and well-tolerated in the short term. So there’s a big question of, well, what’s worse, my kid not sleeping, or my kid taking melatonin once a week?”

As for the answer to that question, she said: “We don’t know.”

Mother’s little helper

The urge—the desperate, frantic, all-consuming urge—to get a child to fall sleep is familiar to many parents. So is the impulse to satisfy that urge through drugs. Into the early 20th century, parents sometimes administered an opiate called laudanum to help young children sleep, even though it could be fatal. Decades later, when over-the-counter antihistamines like Benadryl became popular, some parents began using them, off-label, as a sleep aid.

“Most people are pretty happy to resort to over-the-counter medication if their kids are not sleeping,” one mother of two small kids told a team of Australian researchers for a 2004 study. “It really saves the children’s lives,” she added, because “it stops mums from throwing them against the wall.”

Compared to other sleep aids, melatonin supplements have obvious advantages. Chief among them is that they mimic a natural hormone: The body secretes melatonin from a pea-sized gland nestled in the brain, typically starting in the early evening. Levels peak after midnight, and drop off a few hours before sunrise.

Artificially boosting melatonin helps many people fall sleep earlier or more easily.

“There’s a big question of, well, what’s worse, my kid not sleeping, or my kid taking melatonin once a week?”

When a child takes a 1 milligram dose of melatonin, the hormone quickly enters their bloodstream, signaling to the brain that it’s time for sleep. Melatonin reaches levels in the blood that can be more than 10 times higher than natural peak concentrations. Soon, many children begin to feel drowsy.

Children can generally tolerate melatonin. Known side effects appear to be mild, and, compared to antihistamines, people taking low doses of melatonin are less likely to wake up feeling groggy the next morning.

As early as 1991, some researchers began administering small doses of the hormone to children with autism, who sometimes have extreme difficulty falling and staying asleep. A series of trials conducted in the Netherlands in the 2000s found that melatonin could also have modest benefits for non-autistic children experiencing insomnia, and it seemed to be safe in the short-term—although the long-term consequences of regularly taking the hormone were unclear.

The timing of the research coincided with a move in the US to loosen regulations on dietary supplements, led by Sen. Orrin Hatch of Utah, a supplement-industry hub.

News reports suggest that, by the late 2000s, some parents were trying melatonin for older children.

It’s hard to know for sure who first decided to market melatonin specifically to children, but a key player seems to be Zak Zarbock, a Utah pediatrician and father of four boys who, in 2008, began selling a drug-free, honey-based cough syrup. In 2011, his company, Zarbee’s, introduced a version of its children’s cough remedy that contained melatonin. Soon after, Zarbee’s launched a line of melatonin supplements tailored to children. In a 2014 press release, Zarbock stressed that “a child shouldn’t need to take something to fall asleep every night.” But melatonin, he said, could act like “a reset button for your bedtime routine” when things got out-of-whack. (Zarbock did not respond to interview requests.)

More products followed, and usage rates have climbed. One possible reason for that is that American children are having more difficulty falling asleep. Some experts think screen use is causing sleep problems, and rising rates of anxiety and depression among children may also be affecting slumber. Clinicians report treating families that use melatonin to counteract the stimulating effects of caffeine.

Another possibility—and they’re not mutually exclusive—is that supplement makers sensed a market opportunity and seized it. Gummies have made melatonin more palatable to children; supplement makers now market widely to parents online. At least one company seems to have made overtures to parents via a pediatrics organization: Vicks ZzzQuil, a popular line of children’s melatonin products, sponsored a 2020 webinar on sleep hosted by the American Academy of Pediatrics.

How to anger sleep scientists

Is melatonin a harmless natural supplement or a sleep drug? The culture, at times, seems unsure: It’s easy to find parents fretting in online forums about whether the gummies are safe. Daycare workers have undergone criminal prosecution after providing melatonin to their charges without parental consent.

In their marketing, meanwhile, supplement companies consistently describe their melatonin products as drug-free, non-habit-forming, and safe. In one promotional video for Zarbee’s, Zarbock, wearing sky-blue scrubs, tells parents that “in recent short- and long-term studies, melatonin has been shown to be safe and effective for children.” Echoing language used across the industry, Zarbee’s melatonin gummies are marketed today as “safe and drug-free.”

Such claims raise hackles among sleep scientists. “That kind of advertising is unconscionable,” wrote Kennaway, the Adelaide professor, in an email. “Melatonin ingested whether in a gummy or a tablet is being administered as a drug,he wrote. (In a brief statement sent by Tyra Weeks, a spokesperson, Zarbee’s noted its melatonin products are “regulated as a dietary supplement ingredient by the FDA,” adding that they “do not contain active pharmaceutical ingredients.”)

What’s behind the growing use of melatonin to help children sleep? Some experts think screen use is causing sleep problems, and rising rates of anxiety and depression among children may also be affecting slumber.

Credit: Johner Images/Getty Images

What’s behind the growing use of melatonin to help children sleep? Some experts think screen use is causing sleep problems, and rising rates of anxiety and depression among children may also be affecting slumber. Credit: Johner Images/Getty Images

Among other things, Kennaway worries that long-term melatonin use could have unintended effects, including on the developing reproductive system. While it is known that melatonin can interact with lots of tissues, not just the parts of the brain responsible for initiating sleep, many experts note that there is little long-term safety data on supplemental use of the compound.

“Don’t be fooled by thinking that somehow, this is like a vitamin. It’s a drug,” said Owens, the Harvard sleep specialist. “It’s a medication. And there are no really long-term studies that have looked at things like impact on pubertal development.” (Jess Shatkin, a child psychiatrist at New York University’s medical school, noted that such gaps are common even for marquee prescription medications: “I don’t know of a safety study of Zoloft that goes more than two years,” he said, by way of an example.)

Owens has been in clinical practice for 35 years. The arrival of melatonin, she said, felt abrupt: Around 10 years ago, it suddenly seemed that every patient in her clinic was taking it. She is concerned now about inappropriate use, including caregivers using the hormone for children who do not have insomnia; she has heard reports of a summer camp nurse handing it out to campers at bedtime.

“One of the things that disturbs me the most is when I hear a parent say, ‘Oh well, she asks for her melatonin every night and she says she can’t sleep without it,’” Owens said. “You’re setting up a potential lifetime of dependence on sleeping medication.” (Owens has testified in a lawsuit against Zarbee’s, and she consults for AGB-Pharma, a Swedish firm that makes a prescription melatonin drug.)

Is melatonin a harmless natural supplement or a sleep drug? The culture, at times, seems unsure.

Owens and other researchers say melatonin can be helpful for children with neurodevelopmental disorders like autism and ADHD, who may otherwise be unable to establish a stable sleep routine. And they say it may be useful for other children who struggle to sleep—with certain safeguards.

Recently, teams of researchers in Europe and the United States have evaluated what melatonin can do. Edemann-Callesen, the Danish researcher, works at the Centre for Evidence-Based Psychiatry. She recently led a team to systematically collect and review published studies of melatonin in children. The evidence, she said, was mixed. Studies suggest that melatonin can help children fall asleep around 15 or 20 minutes earlier, on average. Whether that translates to a more rested kid is less clear: “When you look at the evidence,” she said, “melatonin doesn’t affect daytime functioning.”

Overall, she said, there just isn’t much research out there to draw on.

In both the US and Europe, experts are converging on certain recommendations: Families should consult a health care provider before use. They should try simple, non-pharmacological steps to improve sleep first, and only turn to melatonin if that fails. They should start with a low dose—typically around 0.5 mg. And they should only use melatonin for a few weeks as a kind of crutch, ideally dosing the hormone to help establish a better sleep routine and then weaning the child off the supplement.

Some families have been scared off by alarming reports about melatonin. Malow, the Vanderbilt sleep expert, began studying melatonin in the 2000s, as a sleep aid for children with autism. Recently, she said, some families who rely on the supplement to help their children have gotten jumpy: “I had a lot of families tell me in clinic, ‘I’m really worried about melatonin. I read this, I read that, is it safe?” She makes sure they’re using a brand that submits its products to external certification. “And I’d be like, you know, it’s working. It’s working for your kid. Why stop it?”

In 2021, Malow and several colleagues published a study of melatonin safety, looking at 80 children and adolescents who had taken the hormone over the course of two years. They did not flag any serious side effects, and the children’s puberty seemed to progress normally. (The study was funded by Neurim Pharmaceuticals, which manufactures a melatonin drug prescribed outside the US.)

Malow acknowledged the study was small, but she said the findings aligned with her own years of clinical experience. “At least it’s something,” she said. “And I have not, in my experience, had any kids where I was concerned, or the parents were concerned, that puberty was delayed because of melatonin use.”

Consult with your family doctor

Last year, the Council for Responsible Nutrition, a leading supplement industry group, published voluntary guidelines for its members. Among them: put products in child deterrent packaging; tell people to consult a pediatrician before using melatonin; and warn caregivers that melatonin is “for occasional and/or intermittent use only.”

Plenty of manufacturers aren’t part of CRN, and it’s not hard to find suppliers that aren’t in compliance with those recommendations. And whether parents follow the recommendations is something else entirely. User reviews and academic surveys indicate that some parents are dosing regularly for months or years on end, and the products themselves seem packaged for long-term use: For example, the company MaryRuth’s sells bottles of children’s melatonin gummies labeled “2 month supply.” Natrol, a popular brand that warns caregivers that the product is “for occasional short-term use only,” sells bottles containing 140 doses. (MaryRuth’s did not respond to requests for comment, and a spokesperson for Natrol declined to comment.)

Meanwhile, as melatonin sales climb, a growing body of evidence points to cases of misuse.

One issue: Children seem to be sometimes finding, and swallowing, gummies and other melatonin products. Calls to poison control centers for pediatric melatonin ingestion increased 530 percent between 2012 and 2021, according to one analysis published by the US Centers for Disease Control and Prevention.

Mostly, nothing happened: Among small children, the large majority of the incidents were resolved without the child experiencing symptoms at all. When symptoms do appear, they tend to be mild—drowsiness, for example, or gastrointestinal upset. (Achieving a lethal dose of melatonin appears to be virtually impossible, said Laura Labay, a forensic toxicologist at NMS Labs, which provides toxicology testing services.)

Still, some experts have expressed concern that melatonin misuse might, in rare cases, contribute to more serious outcomes.

In 2015, Sandra Bishop-Freeman, now the chief toxicologist at the North Carolina Office of the Chief Medical Examiner, was called to review on a tragic case. A 3-month-old girl had died in her crib. More than 20 bottles of melatonin were found in the home, and an investigation showed that the girl and her twin sister had been given 5 milligram doses of melatonin multiple times per day to help them sleep. The infant’s blood levels of melatonin were orders of magnitude above the natural range.

“Oftentimes when I explore topics, it’s because we find things that were previously unknown or confusing to us,” Bishop-Freeman told Undark. She wasn’t sure if melatonin had contributed to the infant’s death. But as she read more about the hormone, she felt concerns, especially when her office received several more cases involving elevated levels of melatonin. “It was hard to just tell the pathologist, ‘Eh, no worries, everyone thinks it’s safe, so you’re fine,’” she said.

User reviews and academic surveys indicate that some parents are dosing regularly for months or years on end, and the products themselves seem packaged for long-term use.

In 2022, Bishop-Freeman and colleagues published a paper detailing seven cases of undetermined pediatric deaths where bloodwork revealed elevated levels of melatonin. (They’ve seen more since finishing the paper.) “We don’t want to overstate these findings,” she said: The causes of the deaths are unknown, and the presence of melatonin may just be a coincidence. But her team can’t rule out the hormone as a possible contributor, she said, and investigators should be alert to elevated melatonin levels, which may sometimes be overlooked.

Labay, the forensic toxicologist, said she found those concerns plausible. But, she added, “I think I’m still waiting for the paper that says, ‘This was a pure melatonin death and there was no other contributing cause to that death.'”

Melatonin gummies have made the drug more palatable to children, and supplement makers now market them widely to parents online. But data suggests that the widespread availability of the supplements, often resembling candy, can lead to misuse.

Credit: Joe Raedle/Getty Images

Melatonin gummies have made the drug more palatable to children, and supplement makers now market them widely to parents online. But data suggests that the widespread availability of the supplements, often resembling candy, can lead to misuse. Credit: Joe Raedle/Getty Images

As more children take melatonin, some experts want the supplement industry to do more to prevent them from taking too-large quantities. Pieter Cohen, an internist and a prominent critic of supplement industry practices, faulted regulators for not requiring childproof caps and questioned why companies sell what he describes as higher-than-necessary doses of the hormone.

Many products also have considerably more melatonin than is listed on the label. Last year, a US Food and Drug Administration team analyzed melatonin content in 110 products that appeared in online searches for things like “melatonin + child,” and found dozens of mismatches. In one case, a product contained more than six times the amount on the label.

The study was submitted to a journal in July 2024. So far, the agency has not taken any public action against those companies. “The FDA is not doing their job. They’re basically cowering to the industry,” Cohen said.

In a statement from the FDA, sent by spokesperson Lindsay Haake, the agency said that the products analyzed in the study were “individually evaluated to determine if any agency follow up was needed.” The statement added that “we do not discuss potential or ongoing compliance or enforcement matters with third parties.”

“The FDA is not doing their job. They’re basically cowering to the industry.”

Steve Mister, the president and CEO of the Council for Responsible Nutrition, said manufacturers often have to sell products with higher levels in order to make sure there’s melatonin available throughout a product’s shelf-life. Those so-called overages, he stressed, are modest and safe: “Whatever we put in, we still have confidence that it is safe on day one,” he said.

The supplement industry, Mister said, has taken ­steps to ensure that melatonin is used responsibly, including the guidelines his organization issued last year. “I think our voluntary program is an illustration that we want to step up and do some education of parents,” he said.

He pushed back against suggestions that the supplement industry was not a responsible steward of melatonin, or that it was unwise for the hormone to be sold as an over-the-counter supplement: “Look at the safety and look at the number of doses that are sold in this country every year, and how few adverse events there are, and how little evidence that there is a concern,” Mister said. Other countries, he added, may choose to limit melatonin to prescription-use only. “They like the way their system is set up. That doesn’t mean that it’s right for the US.”

Bedtime struggles take a toll on everyone

For parents whose children struggle to fall sleep, the costs of an interminable bedtime can feel high: exhausted children, burned-out parents, and family conflict that stretches into the night. In online videos and forums, parents disclose insecurity (“We are now at the stage in parenthood where we drug our kids,” one mother says in a TikTok) and gratitude (“It’s saved our sanity,” writes a parent on Reddit). Caregivers talk about their children getting better rest—but it can seem as if the supplement is as much for parents’ mental health as it is for children’s restful sleep.

From the vantage point of a chaotic bedtime, the safety concerns about melatonin can feel academic, privileging unknown or speculative harms (such as the possibility of long-term side effects) over the chance of immediate relief. In conversations, physicians and psychologists who devote their careers to children’s sleep stress the importance of a good night’s rest. But some worry melatonin is often used as a shortcut—and suggest there are more effective paths to improved sleep that families could take, especially if they had better support.

For parents whose children struggle to fall sleep, the costs of an interminable bedtime can feel high: exhausted children, burned-out parents, and family conflict that stretches into the night.

Candice Alfano, a professor of psychology at the University of Houston, runs a center devoted to studying childhood sleep and anxiety. In 2020 and 2021, she and her team conducted a survey of sleep health among children in foster care, who struggle with insomnia at far higher rates than the general population. Pharmacological treatments, they found, were widespread: More than one in 10 foster parents reported receiving a prescription medicine to help the children sleep. And close to half were using melatonin at least occasionally—and often regularly—to help the children sleep.

Alfano’s team has recently developed a sleep treatment program for foster families that, she said, may offer an alternative intervention to drugs and supplements. The initial findings, from a small pilot, suggest it’s effective.

The appeal of melatonin, though, remains, both for caregivers and for the pediatricians who advise them, Alfano said: “It’s seemingly a quick and easy suggestion: ‘You know, here’s something you could go get over the counter. You don’t even need a prescription from me.’”

But the goal, she said, is something else: “to teach these children how to sleep, rather than just sleep.”

This article was originally published on Undark. Read the original article.

Parents give kids more melatonin than ever, with unknown long-term effects Read More »

wealthy-americans-have-death-rates-on-par-with-poor-europeans

Wealthy Americans have death rates on par with poor Europeans

“The findings are a stark reminder that even the wealthiest Americans are not shielded from the systemic issues in the US contributing to lower life expectancy, such as economic inequality or risk factors like stress, diet or environmental hazards,” lead study author Irene Papanicolas, a professor of health services, policy and practice at Brown, said in a news release.

The study looked at health and wealth data of more than 73,000 adults across the US and Europe who were 50 to 85 years old in 2010. There were more than 19,000 from the US, nearly 27,000 from Northern and Western Europe, nearly 19,000 from Eastern Europe, and nearly 9,000 from Southern Europe. For each region, participants were divided into wealth quartiles, with the first being the poorest and the fourth being the richest. The researchers then followed participants until 2022, tracking deaths.

The US had the largest gap in survival between the poorest and wealthiest quartiles compared to European countries. America’s poorest quartile also had the lowest survival rate of all groups, including the poorest quartiles in all three European regions.

While less access to health care and weaker social structures can explain the gap between the wealthy and poor in the US, it doesn’t explain the differences between the wealthy in the US and the wealthy in Europe, the researchers note. There may be other systemic factors at play that make Americans uniquely short-lived, such as diet, environment, behaviors, and cultural and social differences.

“If we want to improve health in the US, we need to better understand the underlying factors that contribute to these differences—particularly amongst similar socioeconomic groups—and why they translate to different health outcomes across nations,” Papanicolas said.

Wealthy Americans have death rates on par with poor Europeans Read More »